Loading...
XHKG
9933
Market cap196mUSD
Jul 09, Last price  
1.63HKD
1D
8.67%
1Q
-7.91%
IPO
386.57%
Name

GHW International

Chart & Performance

D1W1MN
XHKG:9933 chart
P/E
104.79
P/S
0.32
EPS
0.01
Div Yield, %
Shrs. gr., 5y
-0.85%
Rev. gr., 5y
14.35%
Revenues
4.11b
+6.51%
1,606,829,0002,179,049,0002,152,946,0001,966,055,0002,103,882,0002,833,268,0003,378,707,0003,217,669,0003,861,966,0004,113,198,000
Net income
13m
-0.28%
19,148,00078,223,00074,257,00029,107,000-5,175,000130,713,000274,627,0002,724,00012,753,00012,717,000
CFO
240m
+293.98%
69,024,00054,351,00019,801,00020,196,000-125,223,000-122,525,000234,079,000120,070,00061,036,000240,470,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GHW International is an investment holding company that manufactures and globally distributes a variety of chemical and pharmaceutical products. Its operations reach across the People's Republic of China, Europe, Vietnam, other Asian regions, and various international markets. The company organizes its business into four primary divisions: Polyurethane Materials, Animal Nutrition Chemicals, Fine Chemicals, and Pharmaceutical Products and Intermediates. The Polyurethane Materials division supplies polymeric methylene diphenyl diisocyanate (PMDI), toluene diisocyanate (TDI), and polymer polyether, which are integral to the production of cushion foams, vehicle interior components, and other lightweight automotive parts. Its Animal Nutrition Chemicals segment provides choline chloride and betaine, essential compounds used in feed formulations for poultry and livestock. The Fine Chemicals division produces various substances, including carboxylic acids, solvents, resins, and oleochemicals. These find applications in paints, dye synthesis, lubricant manufacturing, emulsifiers, cosmetics, flavors, fragrances, and feed additives. Lastly, the Pharmaceutical Products and Intermediates segment manufactures and markets compounds like isooctanoic acid and diethyl sulfate. These are utilized as paint driers, fungicides, preservatives, and pharmaceutical raw materials, as well as in the synthesis of dyes, pesticides, and pharmaceutical intermediates. This segment also offers iodine and its derivatives, along with finished pharmaceutical products, such as cefpodoxime dispersible tablets. GHW International was established in 1995 and its main offices are situated in Nanjing, People's Republic of China.
IPO date
Jan 21, 2020
Employees
1,108
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT